At the IGTP TODAY

News

- Research

New community strategies to promote Health and screening for the micro-elimination of hepatitis C in migrants

The project is a pilot programme for the implementation and validation of the micro-elimination of Hepatitis C based on a community strategy. The validation has focussed on a migrant Pakistani population in Barcelona and the metropolitan area and is now being extended to migrants from other countries where the disease is endemic and to screening for Hepatitis B. The study unites two previously validated strategies to bring education about hepatitis (VHIR) and diagnostics (IGTP) to these vulnerable populations in the community.

- Research

The CMCiB, ready for advanced research on SARS-CoV-2

The Centre for Comparative medicine and Bioimage (CMCiB) of the IGTP has its level 3 biological containment laboratories (BCLL3) ready to receive new projects related to the study of the SARS-CoV-2 virus. These facilities are biological containment areas designed for work on microorganisms that cause infectious diseases, especially those with a high risk of transmission through the diffusion of aerosols.

- Institutional

Julia Garcia-Prado selected for the EATRIS Scientific Committee in Spain

Dr Julia Garcia Prado, Scientific Director of the IGTP and Leader of the VIRIEVAC Group at IrsiCaixa, has been appointed member of the new EATRIS Scientific Committee for Spain. The new body is part of the strategic plan of action for the EATRIS Spain node to increase its presence in the network and increase strategic international collaborations between biomedical research institutes.

- Research

Plasmodium vivax parasites are shown to be present and causing changes in bone marrow during Malaria Infections

Three groups from the IGTP have collaborated on a study of the parasite Plasmodium vivax with several Brazilian groups. The paper published in the Journal of Infectious Diseases provides proof of the presence of P. vivax in bone marrow during infections, something which has been controversial until now. They also showed that it disrupts normal red blood cell production, as well as altering the immune response.

- Projects, Research

Full marks for the mid-term meeting of the European Project INNOVA4TB coordinated from the IGTP

At the start of Julio the mid-tem meeting of the European project "Innovation in Tuberculosis-INNOVA4TB", designed and coordinated by the Innovation in Respiratory Infections and Tuberculosis Diagnosis research group led by Dr José Dominguez and Cristina Prat took place. INNOVA4TB is a European Project focused on the diagnosis and clinical handling of tuberculosis financed by a Marie Skłodowska Curie award.

- Research

The IGTP cytometry core facility is a reference for spectral cytometry in Europe

The Cytometry core facility, headed by Dr Marco Antonio Fernández, is one of the 9 European laboratories developing multidimensional panels for spectral cytometry to study the immune response to COVID-19 with the company Cytek Biosciences. Now the IGTP is one of the reference centres in this technology, the result of work in laboratories in Holland, the United Kingdom, France, Germany and Spain.

- Research

Scientists from CEEISCAT to update HIV epidemiological surveillance protocols for Latin America and the Caribbean

The CEEISCAT, a research group led by Dr Jordi Casabona and affiliated with the IGTP, has been commissioned by the Pan American Health Organization (PAHO) to update the epidemiological surveillance protocols for HIV in Latin America and the Caribbean. The objective is to draw up a new epidemiological surveillance, and monitoring and evaluation protocol for HIV infection. With this new guide the international recommendations can be adapted to the different regions of Latin America, establishing basic concepts and clarifying the quality regulations that reinforce epidemiological surveillance.

- Research

Advance for researchers from the IGTP and ISGLobal seeking biomarkers for Chagas disease

Extracellular vesicles (EVs) that circulate in the blood of Chagas disease patients are a valuable tool to identify potential markers of therapeutic response, according to a study led by researchers at the ISGlobal, an institution supported by "la Caixa",  and the IGTP. With this strategy, the research team identified for the first time a series of proteins, including one from the parasite, that could serve to assess the response to existing or new treatments

- Research

Three IGTP projects selected by the CaixaImpulse Validate Programme

The "la Caixa" Foundation has announced the 23 projects selected for the two arms of the CaixaImpulse Programme in this year's call. 20 are projects in the CaixaImpulse Validate call and three of these are led by the IGTP. These initiatives are focussed on resolving big health challenges such as: resistance to cancer treatment; complications in eye surgery and the use of microwaves to detect stent failures in implanted heart disease patients.